Skip to content

Positive pressure oxygen therapy combined with improvement of pulmonary circulation to improve the rescue efficiency of COVID-19 at high altitude

Positive pressure oxygen therapy combined with improvement of pulmonary circulation to improve the rescue efficiency of COVID-19 at high altitude

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074359
Enrollment
Unknown
Registered
2023-08-04
Start date
2023-08-11
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 pneumonia

Interventions

Intervention treatment group:Positive pressure oxygen therapy combined with drug therapy to improve Pulmonary circulation
contral group:Routine treatment of COVID-19

Sponsors

People's Hospital of Xi Zang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Age 18-85 years old; ? Check in the Intensive care medicine Department of the hospital, and diagnosed as COVID-19 severe, critical cases or ordinary cases with basic heart and lung diseases (COVID-19 pneumonia diagnosis and classification is based on the Diagnosis and Treatment Plan of novel coronavirus Pneumonia (Ninth Edition)); ? The patient signs an informed consent form.

Exclusion criteria

Exclusion criteria: ? The patient has positive pressure oxygen therapy related Contraindication; ? serious shock and other Contraindication to use drugs to improve Pulmonary circulation; ? Pregnant or lactating women; ? Patients who refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
hospital stay;Hospitalization expenses;Hospitalization costs Positive pressure oxygen therapy time;Time of virus turning negative;Tracheal intubation rate;Incidence of pulmonary bacterial infections;90 days survival rate;

Countries

china

Contacts

Public ContactJie Lu

People's Hospital of Xi Zang Autonomous Region

bhonghonga@163.com+86 138 1052 0238

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026